Please assess the completion status of the following clinical trial:

Trial Title: Study of Recombinant Human Thrombin for Bleeding During Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is undergoing spinal surgery, hepatic resection, peripheral arterial bypass surgery, or arteriovenous graft formation for hemodialysis access~Exclusion Criteria:~* Subject has undergone a therapeutic surgical procedure within 30 days prior to surgery~* Subject has history of heparin-induced thrombocytopenia~* Subject has known antibodies or hypersensitivity to thrombin or other coagulation factors or known sensitivity to other components of the study treatment~* Subject has received blood products within 24 hours prior to surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): rThrombin
- 2 (Type: ACTIVE_COMPARATOR): bThrombin

Based on this trial design, predict the completion outcome and termination type (if applicable).